- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant adeno-associated viral vector serotype 6 encodin
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant adeno-associated viral vector serotype 6 encoding the B-domain-deleted human factor VIII
| EU orphan designation number: | EU/3/17/1874
|
| Active ingredient: | Recombinant adeno-associated viral vector serotype 6 encoding the B-domain-deleted human factor VIII |
| Indication: | Treatment of haemophilia A |
| Sponsor: | Coté Orphan Consulting UK Limited
c/o Elemental CoSec, 27 Old Gloucester Street, London WC1N 3AX, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 23/05/2017 | Orphan designation | EMA/OD/019/17 | (2017)3607 of 22/05/2017 |
CONTACT
EU links
Directorate General Health & Consumers